Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

467 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Trial watch: dendritic cell vaccination for cancer immunotherapy.
Sprooten J, Ceusters J, Coosemans A, Agostinis P, De Vleeschouwer S, Zitvogel L, Kroemer G, Galluzzi L, Garg AD. Sprooten J, et al. Among authors: Galluzzi L. Oncoimmunology. 2019 Jul 18;8(11):e1638212. doi: 10.1080/2162402X.2019.1638212. eCollection 2019. Oncoimmunology. 2019. PMID: 31646087 Review.
Targeting HSP70 for cancer therapy.
Galluzzi L, Giordanetto F, Kroemer G. Galluzzi L, et al. Mol Cell. 2009 Oct 23;36(2):176-7. doi: 10.1016/j.molcel.2009.10.003. Mol Cell. 2009. PMID: 19854128
Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy.
Kepp O, Galluzzi L, Martins I, Schlemmer F, Adjemian S, Michaud M, Sukkurwala AQ, Menger L, Zitvogel L, Kroemer G. Kepp O, et al. Among authors: Galluzzi L. Cancer Metastasis Rev. 2011 Mar;30(1):61-9. doi: 10.1007/s10555-011-9273-4. Cancer Metastasis Rev. 2011. PMID: 21249425 Review.
Trial Watch: Monoclonal antibodies in cancer therapy.
Galluzzi L, Vacchelli E, Fridman WH, Galon J, Sautès-Fridman C, Tartour E, Zucman-Rossi J, Zitvogel L, Kroemer G. Galluzzi L, et al. Oncoimmunology. 2012 Jan 1;1(1):28-37. doi: 10.4161/onci.1.1.17938. Oncoimmunology. 2012. PMID: 22720209 Free PMC article.
Trial watch: Chemotherapy with immunogenic cell death inducers.
Vacchelli E, Galluzzi L, Fridman WH, Galon J, Sautès-Fridman C, Tartour E, Kroemer G. Vacchelli E, et al. Among authors: Galluzzi L. Oncoimmunology. 2012 Mar 1;1(2):179-188. doi: 10.4161/onci.1.2.19026. Oncoimmunology. 2012. PMID: 22720239 Free PMC article.
Loss-of-function alleles of P2RX7 and TLR4 fail to affect the response to chemotherapy in non-small cell lung cancer.
Vacchelli E, Galluzzi L, Rousseau V, Rigoni A, Tesniere A, Delahaye N, Schlemmer FD, Menger L, Sukkurwala AQ, Adjemian S, Martins I, Michaud M, Dunant A, Kepp O, Brambilla E, Soria JC, Zitvogel L, Kroemer G. Vacchelli E, et al. Among authors: Galluzzi L. Oncoimmunology. 2012 May 1;1(3):271-278. doi: 10.4161/onci.18684. Oncoimmunology. 2012. PMID: 22737602 Free PMC article.
Trial Watch: Adoptive cell transfer immunotherapy.
Galluzzi L, Vacchelli E, Eggermont A, Fridman WH, Galon J, Sautès-Fridman C, Tartour E, Zitvogel L, Kroemer G. Galluzzi L, et al. Oncoimmunology. 2012 May 1;1(3):306-315. doi: 10.4161/onci.19549. Oncoimmunology. 2012. PMID: 22737606 Free PMC article.
Trial Watch: Immunostimulatory cytokines.
Vacchelli E, Galluzzi L, Eggermont A, Galon J, Tartour E, Zitvogel L, Kroemer G. Vacchelli E, et al. Among authors: Galluzzi L. Oncoimmunology. 2012 Jul 1;1(4):493-506. doi: 10.4161/onci.20459. Oncoimmunology. 2012. PMID: 22754768 Free PMC article.
Trial Watch: Experimental Toll-like receptor agonists for cancer therapy.
Galluzzi L, Vacchelli E, Eggermont A, Fridman WH, Galon J, Sautès-Fridman C, Tartour E, Zitvogel L, Kroemer G. Galluzzi L, et al. Oncoimmunology. 2012 Aug 1;1(5):699-716. doi: 10.4161/onci.20696. Oncoimmunology. 2012. PMID: 22934262 Free PMC article.
Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy.
Vacchelli E, Galluzzi L, Eggermont A, Fridman WH, Galon J, Sautès-Fridman C, Tartour E, Zitvogel L, Kroemer G. Vacchelli E, et al. Among authors: Galluzzi L. Oncoimmunology. 2012 Sep 1;1(6):894-907. doi: 10.4161/onci.20931. Oncoimmunology. 2012. PMID: 23162757 Free PMC article.
467 results
Jump to page
Feedback